RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Valeo Pharma Stock

Valeo Pharma ROCE 2024

Valeo Pharma ROCE

0.43

Ticker

VPH.TO

ISIN

CA91915B1085

WKN

A2PLB4

In 2024, Valeo Pharma's return on capital employed (ROCE) was 0.43, a -60.11% increase from the 1.07 ROCE in the previous year.

Valeo Pharma Aktienanalyse

What does Valeo Pharma do?

Valeo Pharma Inc is a pharmaceutical company that was founded in 2003. It is based in Montreal, Canada and its stocks are traded on the Toronto Stock Exchange. The company specializes in the development, manufacturing, and marketing of innovative pharmaceutical and medical products to help patients in Canada and around the world. Valeo Pharma's business model is based on identifying unmet medical needs, particularly in niche markets where there is a demand for innovative solutions. The company recognizes that there are difficulties for patients and healthcare professionals in finding specific medications suitable for their treatment needs in these niche markets. Valeo Pharma aims to fill this gap by developing innovative products tailored to the specific needs of patients and professionals, differentiating itself from other standard products. Valeo Pharma operates in two main business areas: Pharmaceuticals and OTC - Over-the-Counter. The pharmaceutical division of Valeo Pharma focuses on the development of drugs for the treatment of diseases that are currently inadequately treated. Their products in this area include drugs for the treatment of neurology, oncology, infectious diseases, dermatology, and psychiatry. Valeo Pharma's OTC division specializes in the development of products for self-medication and disease prevention. Their products in this area include pain relief products, cold and cough treatments, and general health support. Some of Valeo Pharma's key products include Blexten, an antihistamine for the treatment of seasonal and perennial allergic rhinitis as well as chronic idiopathic urticaria, and Redesca, a product for the prevention of blood clots and reducing the risk of thrombosis in patients with various medical conditions. Valeo Pharma has formed various partnerships with leading pharmaceutical companies around the world to bring its products to market. Through these partnerships, the company can expand its reach and offer exclusive products to its customers in different regions. Valeo Pharma is committed to research and development of new products that meet the needs of patients and healthcare professionals. The company invests in the development of active substances that treat diseases that are currently inadequately treated or have no effective medical treatments available. Overall, Valeo Pharma has established itself as a leading pharmaceutical company in Canada, focusing on providing innovative products to improve the health and well-being of patients. The company has a strong presence in the Canadian and international pharmaceutical industry and aims to expand its business through the development and marketing of innovative products and the formation of further strategic partnerships with pharmaceutical companies. Valeo Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Valeo Pharma's Return on Capital Employed (ROCE)

Valeo Pharma's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Valeo Pharma's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Valeo Pharma's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Valeo Pharma’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Valeo Pharma stock

What is the ROCE (Return on Capital Employed) of Valeo Pharma this year?

The ROCE of Valeo Pharma is 0.43 undefined this year.

How has the ROCE (Return on Capital Employed) of Valeo Pharma developed compared to the previous year?

The ROCE of Valeo Pharma has increased by -60.11% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Valeo Pharma?

A high Return on Capital Employed (ROCE) indicates that Valeo Pharma has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Valeo Pharma?

A low ROCE (Return on Capital Employed) can indicate that Valeo Pharma has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Valeo Pharma impact the company?

An increase in the ROCE of Valeo Pharma can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Valeo Pharma affect the company?

A decrease in ROCE of Valeo Pharma can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Valeo Pharma?

Some factors that can affect Valeo Pharma's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Valeo Pharma so important for investors?

The ROCE of Valeo Pharma is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Valeo Pharma take to improve the ROCE?

To improve the ROCE, Valeo Pharma can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Valeo Pharma pay?

Over the past 12 months, Valeo Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Valeo Pharma is expected to pay a dividend of 0 CAD.

What is the dividend yield of Valeo Pharma?

The current dividend yield of Valeo Pharma is .

When does Valeo Pharma pay dividends?

Valeo Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Valeo Pharma?

Valeo Pharma paid dividends every year for the past 0 years.

What is the dividend of Valeo Pharma?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Valeo Pharma located?

Valeo Pharma is assigned to the '-' sector.

Wann musste ich die Aktien von Valeo Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Valeo Pharma from 11/6/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 11/6/2024.

When did Valeo Pharma pay the last dividend?

The last dividend was paid out on 11/6/2024.

What was the dividend of Valeo Pharma in the year 2023?

In the year 2023, Valeo Pharma distributed 0 CAD as dividends.

In which currency does Valeo Pharma pay out the dividend?

The dividends of Valeo Pharma are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Valeo Pharma

Our stock analysis for Valeo Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Valeo Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.